BC
ABBV icon

Brookfield Corp’s AbbVie ABBV Stock Holding History

Brookfield Corp’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-90,875
Closed -$12.2M – 108
2023
Q2 		$12.2M Sell
90,875
-186,673
-67% -$27.4M 0.05% 139
2023
Q1 		$44.2M Buy
277,548
+200,077
+258% +$30.6M 0.17% 61
2022
Q4 		$12.5M Sell
77,471
-78,780
-50% -$12.1M 0.05% 132
2022
Q3 		$21M Buy
+156,251
New +$22.4M 0.08% 94
2022
Q2 		– Sell
-69,609
Closed -$11.3M – 579
2022
Q1 		$11.3M Sell
69,609
-37,268
-35% -$5.41M 0.04% 139
2021
Q4 		$14.5M Buy
106,877
+56,921
+114% +$6.72M 0.06% 100
2021
Q3 		$5.39M Buy
49,956
+31,790
+175% +$3.63M 0.02% 208
2021
Q2 		$2.05M Buy
+18,166
New +$2.05M 0.01% 351

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Brookfield Corp's ABBV Position: Q3 2023 in Review

Brookfield Corp sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 90,875 shares — an estimated $12.2M sold.

Brookfield Corp first reported a position in ABBV in Q2 2021 and held it in 8 quarters. The position peaked at $44.2M in Q1 2023. 3,112 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Brookfield Corp reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 90,875 AbbVie shares in Q3 2023, an estimated $12.2M.
  • Brookfield Corp first reported a position in AbbVie in Q2 2021 and held it in 8 quarters.
  • Brookfield Corp's AbbVie position peaked at $44.2M in Q1 2023.
  • 3,112 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.